Stryker Corp (SYK)
325.50
-2.95
(-0.90%)
USD |
NYSE |
May 06, 16:00
325.18
-0.32
(-0.10%)
Pre-Market: 20:00
Stryker Free Cash Flow: 2.858B for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | 2.858B |
December 31, 2023 | 3.136B |
September 30, 2023 | 2.568B |
June 30, 2023 | 2.417B |
March 31, 2023 | 2.267B |
December 31, 2022 | 2.036B |
September 30, 2022 | 2.015B |
June 30, 2022 | 2.067B |
March 31, 2022 | 2.453B |
December 31, 2021 | 2.738B |
September 30, 2021 | 3.016B |
June 30, 2021 | 2.973B |
March 31, 2021 | 2.712B |
December 31, 2020 | 2.79B |
September 30, 2020 | 2.254B |
June 30, 2020 | 1.96B |
March 31, 2020 | 1.798B |
December 31, 2019 | 1.542B |
September 30, 2019 | 1.898B |
June 30, 2019 | 1.91B |
March 31, 2019 | 2.053B |
December 31, 2018 | 2.038B |
September 30, 2018 | 1.639B |
June 30, 2018 | 1.098B |
March 31, 2018 | 1.125B |
Date | Value |
---|---|
December 31, 2017 | 961.00M |
September 30, 2017 | 983.00M |
June 30, 2017 | 1.43B |
March 31, 2017 | 1.29B |
December 31, 2016 | 1.425B |
September 30, 2016 | 1.584B |
June 30, 2016 | 614.00M |
March 31, 2016 | 524.00M |
December 31, 2015 | 711.00M |
September 30, 2015 | 655.00M |
June 30, 2015 | 1.717B |
March 31, 2015 | 1.744B |
December 31, 2014 | 1.549B |
September 30, 2014 | 1.547B |
June 30, 2014 | 1.65B |
March 31, 2014 | 1.643B |
December 31, 2013 | 1.691B |
September 30, 2013 | 1.622B |
June 30, 2013 | 1.554B |
March 31, 2013 | 1.651B |
December 31, 2012 | 1.447B |
September 30, 2012 | 1.463B |
June 30, 2012 | 1.341B |
March 31, 2012 | 1.042B |
December 31, 2011 | 1.208B |
Free Cash Flow Range, Past 5 Years
1.542B
Minimum
Dec 2019
3.136B
Maximum
Dec 2023
2.370B
Average
2.342B
Median
Free Cash Flow Benchmarks
Boston Scientific Corp | 1.553B |
Haemonetics Corp | 128.75M |
Abbott Laboratories | 4.923B |
Zimmer Biomet Holdings Inc | 1.118B |
ResMed Inc | 1.071B |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 204.00M |
Cash from Investing (Quarterly) | -408.00M |
Cash from Financing (Quarterly) | -418.00M |
Free Cash Flow Per Share (Quarterly) | 0.0961 |
Free Cash Flow to Equity (Quarterly) | 167.00M |
Free Cash Flow to Firm (Quarterly) | 37.00M |
Free Cash Flow Yield | 2.29% |